Patients with rheumatic disease are at a higher risk of infection than the general population. Studies have focused mainly on the infection risk associated with the treatment of rheumatic disease. 1 ...

Mycobacterial diseases, most notably tuberculosis and infections from environmental mycobacteria, represent a significant global health challenge. Their clinical severity is often exacerbated in ...

Please provide your email address to receive an email when new articles are posted on . Mycobacterial disease incidence was significantly higher among patients with vs. without allergic disease.

Background. Mycobacterium abscessus and Mycobacterium massiliense, which cause lung disease, are variable in their clinical manifestation and progression. We hypothesized that mycobacterial genotypes ...

Mycobacterium avium complex (MAC), a type of nontuberculous mycobacteria (NTM), lives all around us. You’ll find these germs in dirt, dust, and drinking water. They’re also common in natural sources ...

A new study examining the public health burden of nontuberculous mycobacterial lung disease in the United States has found that all-cause mortality, adjusted for other factors, more than doubled with ...

Mycobacteria are a group of pathogenic bacteria that cause diseases like leprosy and tuberculosis in humans. Now, a new study finds that mycobacteria are associated with red blood cells at lung ...

If you’re diagnosed with nontuberculous mycobacterial lung disease, your doctor will discuss the right treatment for you. Some people with NTM lung disease don’t need treatment. Others require ongoing ...

After assessing data from the first 46 adults with refractory nontuberculous mycobacterial lung disease who completed the ...

Michio Tsukamura, Hisao Shimoide, Nobuhiko Kita, Keishi Kawakami, Tadao Ito, Naoto Nakajima, Hiroko Kondo, Yoshitaka Yamamoto, Noboru Matsuda, Masatoshi Tamura, Kazuo ...

Tuberculosis (TB) is one of the world's most common infectious diseases. Although infection with the Mycobacterium ...

BOSTON, June 21, 2022 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK) today announced the U.S. Food and Drug Administration has granted Fast Track designation for the oral and IV ...